Frontlight ResearchEarly access
CompletedNo phase
iotaSOFT Pediatric Study
Key facts
- Who runs it
- iotaMotion, Inc.
- Where
- Houston and Iowa City, United StatesSee the 2 sites
- Trial code
- Status
- Completed
- People taking part
- 20 people enrolled
- Started
- 17 May 2022
- Ended
- 10 Jul 2025
- Type of study
- Interventional
- Treatments tested
- iotaSOFT Insertion System
- Record updated
- 6 August 2026
Who can take part
- Age
- 9 months to 12 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Candidate for unilateral or bilateral cochlear implantation according to indications for use with FDA approved cochlear implant devices
- Age 9 months to less than 12 years old at the time of CI surgery
- Willingness to participate in the study and able to comply with the follow-up visit requirements
Who cannot take part
- Prior cochlear implantation in the ear to be implanted
- Planned or current participation in a clinical study of an investigational device or drug
- Active middle-ear infection or tympanic membrane perforation in the presence of active middle-ear disease
- Ossification or any other cochlear anomaly that might prevent complete insertion of the electrode array or present an increased risk of aberrant insertion
- Craniofacial abnormality, temporal squamosal skull thickness less than 3mm, major cochlear lesions, or cochlear malformations
- Deafness due to lesions of the acoustic nerve or central auditory pathway
- Diagnosis of auditory neuropathy
- Absence of cochlear development
- Additional medical concerns that would prevent participation in evaluations as determined by the investigator
Where in United States
- Texas Childrens HospitalHouston, United States
- University of IowaIowa City, United States
About the trial
What the trial wants to find out
Prospective, non-randomized, open-label study to evaluate the safety and efficacy of the iotaSOFT Insertion System when used to assist electrode array insertion during cochlear implant surgery in a pediatric population.
The group in the trial
- Pediatric Cochlear Implant RecipientTreatment being tested
Pediatric subjects receiving a cochlear implant between the ages of 9 months and under 12 years of age who meet prescribed inclusion and exclusion criteria per protocol, signing and Informed Consent and completing active study period; enrollment through 30 days post cochlear implant surgery/activation per investigator site standard of care
Treatment: iotaSOFT Insertion System
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- iotaSOFT Insertion System for Use With Cochlear Implant Surgery in Pediatrics
- Record updated
- 6 August 2026